Chitosan derivatives alone or in combination for the treatment of MDR microbial infections

Details for Australian Patent Application No. 2009313937 (hide)

Owner Synedgen, Inc.

Inventors Baker, Shenda; Wiesmann, William P.; Townsend, Stacy

Agent Cullens

Pub. Number AU-A-2009313937

PCT Pub. Number WO2010/056927

Priority 61/113,983 12.11.08 US; 61/113,982 12.11.08 US; 61/113,904 12.11.08 US

Filing date 12 November 2009

Wipo publication date 20 May 2010

International Classifications

A61K 31/722 (2006.01)

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/056927 Priority application(s): WO2010/056927

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313948-Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]pip eridine compounds

2009313930-E. coli mediated gene silencing of betacatenin